New drugs: transparency

Manufacturers who provide all the information Australian Prescriber requests when assessing a new drug receive the highest score Some companies only provide the approved product information. Although this is helpful, the product information is a public document so does not represent greater transparency. In these cases the T-score from now on will be Manufacturers who say they have no objection to providing information, but then do not deliver it, will be considered to have declined to supply data . The revised T-scores are as follows:

manufacturer provided the product information

manufacturer provided additional useful information

Manufacturer provided the clinical evaluation

manufacturer declined to supply data

manufacturer did not respond to request for data